Skip to content
Advertisement

Packaging for AbbVie's drug, Humira, is photographed in Houston on July 18, 2014. Patients who take the autoimmune disease treatment may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July 2023. (AP Photo/David J. Phillip, File)

Packaging for AbbVie's drug, Humira, is photographed in Houston on July 18, 2014. Patients who take the autoimmune disease treatment may see some price relief when several lower-cost, biosimilar versions of the AbbVie drug reach the U.S. market in July 2023. (AP Photo/David J. Phillip, File)

Featured Photo Galleries